Taken together, Aloxe3 is a fasting-responsive hepatocyte effector that is sufficient to attenuate insulin resistance, weight gain, and hepatic fat deposition in dietary and genetically obese models, in part by activating hepatic PPARγ. The gene discussed is ALOXE3; the disease is Insulin resistance.